Exploring the Genetic Risk of Childhood Daytime Urinary Incontinence: A Genome-Wide Association Study.

The Journal of urology
Authors
Keywords
Abstract

PURPOSE: Childhood incontinence is stigmatized and underprioritized, and a basic understanding of its pathogenesis is missing. Our goal was to identify risk-conferring genetic variants in daytime urinary incontinence (DUI).MATERIALS AND METHODS: We conducted a genome-wide association study in the Danish iPSYCH2015 cohort. Cases (3024) were identified through DUI diagnosis codes and redeemed prescriptions for DUI medication in children aged 5 to 20. Controls (30,240), selected from the same sample, were matched to cases on sex and psychiatric diagnoses, if any, and down-sampled to a 1:10 case:control ratio. Replication was performed in the Icelandic deCODE cohort (5475 cases/287,773 controls). Single-nucleotide polymorphism heritability was calculated using the genome-based restricted maximum likelihood method. Cross-trait genetic correlation was estimated using linkage disequilibrium score regression. Polygenic risk scores generated with LDpred2-auto and BOLT-LMM were assessed for association.RESULTS: Variants on chromosome 6 (rs12210989, OR = 1.24 [95% CI: 1.17-1.32], = 3.21 × 10) and 20 (rs4809801, OR = 1.18 [95% CI: 1.11-1.25], = 3.66 × 10) reached genome-wide significance and implicated the and genes. Chromosome 6 findings were replicated ( = .024, OR = 1.09 [95% CI: 1.01-1.16]). Liability scale heritability ranged from 10.20% (95% CI: 6.40%-14.00%) to 15.30% (95% CI: 9.66%-20.94%). DUI and nocturnal enuresis showed positive genetic correlation ( = 1.28 ± 0.38, = .0007). DUI was associated with attention-deficit/hyperactivity disorder (OR = 1.098 [95% CI: 1.046-1.152], < .0001) and body mass index (OR = 1.129 [95% CI: 1.081-1.178], < .0001) polygenic risk.CONCLUSIONS: Common genetic variants contribute to the risk of childhood DUI and genes important in neuronal development and detrusor smooth muscle activity were implicated. These findings may help guide identification of new treatment targets.

Year of Publication
2024
Journal
The Journal of urology
Pages
101097JU0000000000004187
Date Published
08/2024
ISSN
1527-3792
DOI
10.1097/JU.0000000000004187
PubMed ID
39093873
Links